STARPHARMA HOLDINGS ORDINARY (SPL) Short Interest
STARPHARMA HOLDINGS ORDINARY (ASX:SPL) had 0.10% of shares reported as short positions as of 26 June 2026, representing 436,975 shares. STARPHARMA HOLDINGS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
SPL
Starpharma Holdings
Starpharma Holdings is an Australian biotechnology company focused on developing dendrimer technology for pharmaceutical and life science applications. Their proprietary dendrimer platform is used to improve drug delivery, enhance drug efficacy, and create new pharmaceutical products. The company's market position is built on its innovative technology and partnerships with pharmaceutical companies...